Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/31/2018
Entire Document
 


Accepted and agreed:
OREXIGEN THERAPEUTICS, INC.
By:  

/s/ Thomas P. Lynch

  Name:   Thomas P. Lynch
  Title:  

Executive Vice President,

Chief Administrative Officer,

    General Counsel & Secretary

 

cc:  

Hogan Lovells US LLP

875 Third Avenue

New York, NY 10022
Attention:
     Christopher R. Donoho, III
     Christopher R. Bryant
Email:
     chris.donoho@hoganlovells.com
     chris.bryant@hoganlovells.com

 

[Signature Page to APA Amendment]